Administrative, Leadership Development and Advocacy Core

行政、领导力发展和宣传核心

基本信息

  • 批准号:
    10478811
  • 负责人:
  • 金额:
    $ 32.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-18 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

CORE A: ABSTRACT The SPORE in Prostate Cancer brings together a highly motivated multidisciplinary team of investigators from Northwestern University and the University of Chicago, with contributions from NorthShore University HealthSystem (UC affiliate). The team includes laboratory scientists, urologists, medical oncologists, pathologists, biostatisticians and bioinformaticians, all of whom are dedicated to conducting state-of-the-art translational research to develop and test interventions that improve the outcome of patients diagnosed with prostate cancer. The Administrative, Leadership Development and Advocacy Core has the following Specific Aims: Specific Aim 1: To provide integration within the SPORE, and with the Robert H. Lurie Comprehensive Cancer Center and the University of Chicago Comprehensive Cancer Center Specific Aim 2: To provide strong oversight of research projects and cores as well as financial oversight through planning and evaluation activities Specific Aim 3: To oversee the Developmental Research (DRP) and Career Enhancement (CEP) Programs of the SPORE to encourage investigators to conduct translational prostate cancer research Specific Aim 4: To lead an advocacy group and diversity education initiatives in the community Specific Aim 5: To train the next generation of leaders in prostate cancer research Specific Aim 6: To facilitate collaborations and integration with NIH and other nationally funded programs such as the U54 CA203000 (The Chicago Collaborative to Promote and Advance Cancer Health Equity), Department of Defense and Prostate Cancer Foundation.
核心A:摘要 前列腺癌的孢子汇集了一个高度积极的多学科研究团队, 西北大学和芝加哥大学,北岸大学提供捐助 HealthSystem(UC附属公司)。该团队包括实验室科学家,泌尿科医生,医学肿瘤学家, 病理学家、生物统计学家和生物信息学家,他们都致力于进行最先进的 转化研究,以开发和测试干预措施,改善患者的诊断结果, 前列腺癌 行政、领导力发展和宣传核心有以下具体目标: 具体目标1:提供SPORE内的集成,并与Robert H. Lurie综合癌症 中心和芝加哥大学综合癌症中心 具体目标2:对研究项目和核心项目进行强有力的监督,并通过以下方式进行财务监督: 规划和评价活动 具体目标3:监督以下机构的发展研究和职业发展计划: SPORE鼓励研究人员进行转化前列腺癌研究 具体目标4:在社区领导倡导小组和多样性教育倡议 具体目标5:培养前列腺癌研究的下一代领导者 具体目标6:促进与NIH和其他国家资助项目的合作和整合, 作为U54 CA203000(芝加哥合作促进和推进癌症健康公平),部门 国防和前列腺癌基金会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarki A. Abdulkadir其他文献

Death ligand receptor (DLR) signaling: Its non-apoptotic functions in cancer and the consequences of DLR-directed therapies
死亡配体受体(DLR)信号传导:其在癌症中的非凋亡功能以及 DLR 定向疗法的后果
  • DOI:
    10.1016/j.drudis.2025.104299
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Khalid Rashid;Holger Kalthoff;Sarki A. Abdulkadir;Dieter Adam
  • 通讯作者:
    Dieter Adam
PIM kinase inhibition counters resistance to radiotherapy and chemotherapy in human prostate cancer
PIM激酶抑制可对抗人类前列腺癌对放疗和化疗的耐药性
  • DOI:
    10.1016/j.radonc.2025.110794
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    5.300
  • 作者:
    Anne Rajkumar-Calkins;Vinay Sagar;Jian Wang;Shania Bailey;Philip Anderson;Sarki A. Abdulkadir;Austin N. Kirschner
  • 通讯作者:
    Austin N. Kirschner

Sarki A. Abdulkadir的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarki A. Abdulkadir', 18)}}的其他基金

Small molecule probes of MYC stability and function intumorigenesis
MYC稳定性和肿瘤发生功能的小分子探针
  • 批准号:
    10570873
  • 财政年份:
    2021
  • 资助金额:
    $ 32.6万
  • 项目类别:
Small molecule probes of MYC stability and function intumorigenesis
MYC稳定性和肿瘤发生功能的小分子探针
  • 批准号:
    10361512
  • 财政年份:
    2021
  • 资助金额:
    $ 32.6万
  • 项目类别:
Tumor immune and glycan biomarkers for progressive prostate cancer
进展性前列腺癌的肿瘤免疫和聚糖生物标志物
  • 批准号:
    10305592
  • 财政年份:
    2017
  • 资助金额:
    $ 32.6万
  • 项目类别:
Tumor immune and glycan biomarkers for progressive prostate cancer
进展性前列腺癌的肿瘤免疫和聚糖生物标志物
  • 批准号:
    10053324
  • 财政年份:
    2017
  • 资助金额:
    $ 32.6万
  • 项目类别:
SPORE in Prostate Cancer
前列腺癌中的孢子
  • 批准号:
    10478810
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:
Project 1: Targeting the MYC Pathway in Prostate Cancer
项目 1:靶向前列腺癌中的 MYC 通路
  • 批准号:
    10089063
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:
Administrative, Leadership Development and Advocacy Core
行政、领导力发展和宣传核心
  • 批准号:
    10089060
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:
EPHB4 Receptor Kinase as a Target in Prostate Cancer
EPHB4 受体激酶作为前列腺癌的靶点
  • 批准号:
    8932478
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
整合表观基因组和核受体信号在去势抵抗性前列腺癌中的应用
  • 批准号:
    9103013
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:
Developmental Research Program
发展研究计划
  • 批准号:
    10478823
  • 财政年份:
    2015
  • 资助金额:
    $ 32.6万
  • 项目类别:

相似海外基金

Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
  • 批准号:
    AH/X009637/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Research Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
  • 批准号:
    490127
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Operating Grants
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
  • 批准号:
    2224295
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Continuing Grant
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
  • 批准号:
    484618
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Fellowship Programs
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
  • 批准号:
    23K01937
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
  • 批准号:
    10683644
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
  • 批准号:
    485670
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
  • 批准号:
    487847
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Miscellaneous Programs
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
  • 批准号:
    480718
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
  • 批准号:
    10064859
  • 财政年份:
    2023
  • 资助金额:
    $ 32.6万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了